Valuation: OrthoPediatrics Corp.

Market Cap 494M 432M 400M 368M 695M 47.59B 706M 4.77B 1.87B 23.27B 1.85B 1.81B 80.19B P/E 2026 *
-16.7x
P/E 2027 * -24.4x
Enterprise Value 494M 432M 400M 368M 695M 47.59B 706M 4.77B 1.87B 23.27B 1.85B 1.81B 80.19B EV / Sales 2026 *
1.86x
EV / Sales 2027 * 1.66x
Free-Float
67.15%
Yield 2026 *
-
Yield 2027 * -
1 day+1.59%
1 week-3.98%
Current month+2.04%
1 month+3.44%
3 months+16.54%
6 months+6.38%
Current year+9.91%
1 week 18.6
Extreme 18.6
20.81
1 month 18.07
Extreme 18.07
21.4
Current year 14.42
Extreme 14.42
21.4
1 year 14.42
Extreme 14.42
23.7
3 years 14.42
Extreme 14.42
44.63
5 years 14.42
Extreme 14.42
73.91
10 years 14
Extreme 14.0001
73.91
Manager TitleAgeSince
Chief Executive Officer 47 03/06/2021
Director of Finance/CFO 58 01/02/2015
Chief Tech/Sci/R&D Officer - 01/01/2022
Director TitleAgeSince
Director/Board Member 58 01/08/2015
Chairman 75 03/06/2021
Director/Board Member 67 15/12/2017
Date Insider Type Main position Quantity % Market Cap.
9/6/26 Free

Director

11,436 0.0445%
9/6/26 Free

Director

11,436 0.0445%
9/6/26
Squadron Capital LLC
OtherCompany 0 0%
Change 5-day change 1-year change 3-year change Capi.($)
+1.59%-3.98%-11.31%-56.29% 494M
-0.23%-3.23%-18.04%+8.37% 123B
-1.13%-0.18%+1.16%-4.73% 13.03B
-0.87%+1.79%+59.12%+100.88% 9.21B
+1.67%+14.29%-42.45%-67.47% 4.47B
+0.98%+0.85%+6.39%+47.04% 2.7B
+0.80%-6.61%-22.01%-30.66% 1.62B
+3.55%+3.10%-9.81%-18.90% 1.6B
-0.85%+4.23%+2.09%-58.82% 1.56B
Average +0.61%+1.53%-3.87%-8.95% 17.48B
Weighted average by Cap. -0.22%-1.63%-11.95%+9.66%

Financials

2026 *2027 *
Net sales 265M 232M 215M 197M 373M 25.56B 379M 2.56B 1.01B 12.5B 995M 974M 43.07B 297M 260M 240M 221M 417M 28.6B 424M 2.87B 1.12B 13.98B 1.11B 1.09B 48.18B
Net income -26.4M -23.14M -21.39M -19.67M -37.17M -2.55B -37.75M -255M -100M -1.24B -99.15M -96.98M -4.29B -17.66M -15.47M -14.31M -13.15M -24.86M -1.7B -25.25M -171M -66.96M -832M -66.3M -64.85M -2.87B
Net Debt - -
Logo OrthoPediatrics Corp.
OrthoPediatrics Corp. is an orthopedic company, which is focused on advancing the field of pediatric orthopedics. The Company is engaged in designing, developing, and marketing anatomically appropriate implants and devices for children with orthopedic conditions, giving pediatric orthopedic surgeons and caregivers. The Company sells its specialized products, including PediLoc, PediPlates, Cannulated Screws, PediFlex nail, PediNail, PediLoc Tibia, ACL Reconstruction System, Locking Cannulated Blade, Locking Proximal Femur, Spica Tables, RESPONSE Spine, BandLoc, Devise Rail, Orthex, The Fassier-Duval Telescopic Intramedullary System, SLIM Nail, The GAP Nail, The Free Gliding SCFE Screw System, GIRO Growth Modulation System, PNP Tibia System, ApiFix Mid-C System and Mitchell Ponset specialized bracing products to various hospitals and medical facilities throughout the United States and various international markets. It markets 80 surgical and specialized bracing systems.
Employees
602
Date Price Change Volume
20/07/26 USD 19.52 +1.59% 177,331
17/07/26 USD 19.22 -5.72% 128,149
16/07/26 USD 20.38 +3.35% 168,719
15/07/26 USD 19.72 +2.44% 102,943
14/07/26 USD 19.25 -7.09% 230,405
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
CCC
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
9
Last Close Price
19.52USD
Average target price
25.00USD
Spread / Average Target
+28.07%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. KIDS Stock